Blazer II XP Cardiac Ablation Catheter and Cable
Boston Scientific · Decision date Aug 14, 2025
What did the FDA approve?
FDA records P020025/S146 as a supplement to PMA P020025, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Aug 14, 2025.
FDA approval order statement
for a manufacturing site located at Boston Scientific de Costa Rica, S.R.L., El Coyol Alajuela, Coyol, Costa Rica (FEI: 3007695959) to perform ethylene oxide sterilization activities
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 14, 2025
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P020025/S146
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific
- Product code
- OAD
- Decision code
- APPR
- Decision date
- Aug 14, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.
- Applicant
- Boston Scientific
- Product code
- OAD
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P020025/S146 received
Application receipt date recorded by FDA.
P020025/S146 · FDA decision
Normal 180 Day Track No User Fee
P020025/S147 · Related supplement
RHYTHMIA HDx Ablation Connection Box (for INTELLAGEN) (M004RA65010); Rhythmia HDx Ablation Connection Box (Maestro)
Timeline entries are records held by MedtechLedger for P020025. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P020025
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Boston Scientific | PMA supplement | Oct 17, 2025 | FDA |
Explore the linked device profile
Other records with product code OAD
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
Therapy Dual-8 Ablation CatheterP040042/S060 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Sep 3, 2026 | FDA |
THERMOCOOL SMARTTOUCH SF CatheterP030031/S142 | Biosense Webster, Inc. | PMA supplement | Sep 2, 2026 | FDA |
Ampere GeneratorP040042/S059 | Irvine Biomedical,Inc.(Ibi) | PMA supplement | Aug 7, 2026 | FDA |
Ampere GeneratorP060019/S059 | Irvine Biomedical, Inc. | PMA supplement | Aug 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P020025/S146
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


